Position in UTHR
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$87,523,254
+$8,006,978 QoQ
Shares Held
147,599
-9.6% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,361 | $374,295,531 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
147,599 | $87,523,254 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,765,686 | $53,182,461 | |
| 4 | VTRS |
Viatris Inc
|
3,407,023 | $46,028,880 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
203,637 | $26,827,137 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
78,456 | $5,950,886 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
232,246 | $3,474,399 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
98,313 | $2,352,630 |
All Filings in UTHR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $87,523,254 | 147,599 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $79,516,276 | 163,194 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $54,491,011 | 129,985 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $104,258,050 | 362,826 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $107,953,991 | 350,193 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $41,354,608 | 117,205 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $23,407,418 | 65,320 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $150,671,600 | 472,992 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,910,688 | 165,030 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $41,661,235 | 189,464 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,918,589 | 141,314 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,784,295 | 53,383 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,648,716 | 25,222 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,257,324 | 29,693 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $323,910 | 1,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $360,293 | 1,529 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $310,917 | 1,733 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $406,230 | 1,880 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $347,010 | 1,880 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $337,290 | 1,880 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||